Questcor Pharmaceuticals (QCOR -7.6%) slumps after saying the run-rate of new, paid...

|By:, SA News Editor

Questcor Pharmaceuticals (QCOR -7.6%) slumps after saying the run-rate of new, paid prescriptions for Acthar, a gel treatment for nephrotic syndrome, shows no significant improvment in Q3 over Q2.